Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CardieX ( (AU:CDX) ) has provided an announcement.
Cardiex Limited has successfully raised $2.4 million through a Share Placement to institutional and sophisticated investors and has launched a fully underwritten Entitlement Offer to raise an additional $4.1 million. The funds will support the manufacturing, marketing, and sales of the CONNEQT Pulse device, positioning the company to expand its commercial operations and enhance its supply chain. This capital raise is a strategic move to establish CONNEQT Health as a leader in arterial health solutions, with strong backing from shareholders, including C2 Ventures.
More about CardieX
Cardiex Limited operates in the health technology industry, focusing on arterial health solutions. The company is known for its CONNEQT Health product line, which aims to make arterial health monitoring accessible to a wide audience.
Average Trading Volume: 237,581
Technical Sentiment Signal: Sell
Current Market Cap: A$20.3M
For a thorough assessment of CDX stock, go to TipRanks’ Stock Analysis page.